Dr Veronique Kugener, MD, MsC, MBA was appointed as Senior Vice President and Head Global Pharmacovigilance at Takeda in 2013. Veronique joined legacy Millennium, The Takeda Oncology Company, as Vice President and Head of Pharmacovigilance in 2007. Veronique has over 20 years of experience in clinical drug safety and Pharmacovigilance in the pharmaceutical industry both in Europe and in the USA. Veronique started her career in Global Pharmacovigilance in 1991 at Rhone-Poulenc Rorer and has held positions in clinical drug safety and pharmacovigilance at Aventis, Biogen Idec and Bristol-Myers Squibb.  Veronique received her medical training and earned her medical degree in France .  Veronique received her master degree in advanced studies (DEA) in Epidemiology from the University of Medicine, Victor Segalen in Bordeaux, France and her master degree in Pharmacology from the University of Medicine, Paris VII, France. She is a graduate of the Masters in Business Administration (MBA) from the “Institut of Administration des Entreprises” (IAE) at the University of Bordeaux, France. Veronique and her family reside in the Boston area.